Advisory Services Network’s Global Blood Therapeutics, Inc. GBT Stock Holding History

Advisory Services Network’s Portfolio GBT Stock Details GBT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-36	Closed	-$1K	–	3560
2021 Q2	$1K	Buy	+36	New	+$1.41K	﹤0.01%	3561
2021 Q1	–	Sell	-36	Closed	-$2K	–	3218
2020 Q4	$2K	Sell	36 -23	-39%	-$1.13K	﹤0.01%	3083
2020 Q3	$3K	Sell	59 -5,676	-99%	-$361K	﹤0.01%	3038
2020 Q2	$362K	Sell	5,735 -52	-0.9%	-$3.57K	0.02%	717
2020 Q1	$296K	Buy	5,787 +2	+0%	+$134	0.02%	678
2019 Q4	$460K	Sell	5,785 -327	-5%	-$19.4K	0.02%	643
2019 Q3	$321K	Hold	6,112	–	–	0.02%	675
2019 Q2	$321K	Buy	6,112 +105	+2%	+$6.03K	0.02%	673
2019 Q1	$318K	Buy	+6,007	New	+$295K	0.02%	643

Other funds holding GBT

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return

Advisory Services Network's GBT Position: Q3 2021 in Review

Advisory Services Network sold out of Global Blood Therapeutics, Inc. (GBT) in Q3 2021, closing a stake of 36 shares — an estimated $1K sold.

Advisory Services Network first reported a position in GBT in Q1 2019 and held it in 9 quarters. The position peaked at $460K in Q4 2019. 187 funds tracked by Wall St. Rank hold GBT as of Q3 2021.

Advisory Services Network reported no remaining Global Blood Therapeutics, Inc. position as of Q3 2021 after selling out during the quarter.
Advisory Services Network sold 36 Global Blood Therapeutics, Inc. shares in Q3 2021, an estimated $1K.
Advisory Services Network first reported a position in Global Blood Therapeutics, Inc. in Q1 2019 and held it in 9 quarters.
Advisory Services Network's Global Blood Therapeutics, Inc. position peaked at $460K in Q4 2019.
187 funds tracked by Wall St. Rank held Global Blood Therapeutics, Inc. as of Q3 2021.

Based on Advisory Services Network's 13F filing for Q3 2021, filed 5 Nov 2021.